ABMD - ABIOMED Stock Trading

The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients who are undergoing ECMO treatment and develop pulmonary edema or myocarditis. Impe...

Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% surviv...

Investment Thesis Abiomed 5-year share price performance. Source: TradingView The medical device industry has produced a number of notable share price winners in recent years, owing to advances in technology and the companies that have found ways to apply new technologies to augment or enh...